Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate for refractory partial seizures
NCT00988429Phase 3Completed
- Sponsor
- BIAL
- Start
- Dec 2008
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of eslicarbazepine acetate in partial epilepsy, sponsored by BIAL. Started Dec 2008; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT00988429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00988429.